Kornitzer Capital Management Inc. KS decreased its holdings in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 40.7% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 135,125 shares of the company's stock after selling 92,623 shares during the period. Kornitzer Capital Management Inc. KS's holdings in Roche were worth $4,690,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. HighPoint Advisor Group LLC bought a new position in shares of Roche during the 4th quarter worth $373,000. Associated Banc Corp increased its stake in Roche by 13.8% during the 4th quarter. Associated Banc Corp now owns 48,484 shares of the company's stock valued at $1,761,000 after purchasing an additional 5,890 shares in the last quarter. Bard Financial Services Inc. raised its holdings in shares of Roche by 36.6% in the fourth quarter. Bard Financial Services Inc. now owns 19,800 shares of the company's stock worth $717,000 after buying an additional 5,300 shares during the last quarter. OLD National Bancorp IN lifted its position in Roche by 3.2% during the 2nd quarter. OLD National Bancorp IN now owns 265,242 shares of the company's stock worth $9,206,000 after acquiring an additional 8,146 shares during the period. Finally, Hemenway Trust Co LLC boosted its position in Roche by 86.6% in the first quarter. Hemenway Trust Co LLC now owns 17,981 shares of the company's stock valued at $574,000 after buying an additional 8,345 shares during the last quarter.
Analyst Ratings Changes
A number of equities analysts recently weighed in on RHHBY shares. The Goldman Sachs Group began coverage on Roche in a report on Thursday, May 30th. They issued a "sell" rating for the company. Deutsche Bank Aktiengesellschaft upgraded Roche from a "sell" rating to a "hold" rating in a report on Friday, May 17th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $40.00.
Read Our Latest Stock Analysis on Roche
Roche Price Performance
OTCMKTS:RHHBY traded down $0.15 during mid-day trading on Friday, hitting $40.49. The stock had a trading volume of 1,645,514 shares, compared to its average volume of 2,300,897. The company has a 50 day simple moving average of $39.13 and a 200-day simple moving average of $34.61. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $42.43. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75.
Roche Profile
(
Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Stories
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
